These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22425036)

  • 1. Aluminium overload after 5 years in skin biopsy following post-vaccination with subcutaneous pseudolymphoma.
    Guillard O; Fauconneau B; Pineau A; Marrauld A; Bellocq JP; Chenard MP
    J Trace Elem Med Biol; 2012 Oct; 26(4):291-3. PubMed ID: 22425036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophagic myofasciitis and subcutaneous pseudolymphoma caused by aluminium adjuvants.
    Kim H; Lim KY; Kang J; Park JW; Park SH
    Sci Rep; 2020 Jul; 10(1):11834. PubMed ID: 32678281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Late-onset vaccination-induced subcutaneous pseudolymphoma].
    Croce S; Lhermitte B; Tomasetto C; Guillard O; Bellocq JP; Chenard MP
    Ann Pathol; 2008 Apr; 28(2):146-9. PubMed ID: 18675172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lessons from macrophagic myofasciitis: towards definition of a vaccine adjuvant-related syndrome].
    Gherardi RK
    Rev Neurol (Paris); 2003 Feb; 159(2):162-4. PubMed ID: 12660567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [B-cell pseudolymphoma caused by aluminium hydroxide following hyposensitization therapy].
    Hernández I; Sanmartín O; Cardá C; Góme S; Alfaro A
    Actas Dermosifiliogr; 2008 Apr; 99(3):213-6. PubMed ID: 18358197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aluminium assay and evaluation of the local reaction at several time points after intramuscular administration of aluminium containing vaccines in the Cynomolgus monkey.
    Verdier F; Burnett R; Michelet-Habchi C; Moretto P; Fievet-Groyne F; Sauzeat E
    Vaccine; 2005 Feb; 23(11):1359-67. PubMed ID: 15661384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome.
    Exley C; Swarbrick L; Gherardi RK; Authier FJ
    Med Hypotheses; 2009 Feb; 72(2):135-9. PubMed ID: 19004564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination-induced cutaneous pseudolymphoma.
    Maubec E; Pinquier L; Viguier M; Caux F; Amsler E; Aractingi S; Chafi H; Janin A; Cayuela JM; Dubertret L; Authier FJ; Bachelez H
    J Am Acad Dermatol; 2005 Apr; 52(4):623-9. PubMed ID: 15793512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle.
    Gherardi RK; Coquet M; Cherin P; Belec L; Moretto P; Dreyfus PA; Pellissier JF; Chariot P; Authier FJ
    Brain; 2001 Sep; 124(Pt 9):1821-31. PubMed ID: 11522584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morin Stain Detects Aluminum-Containing Macrophages in Macrophagic Myofasciitis and Vaccination Granuloma With High Sensitivity and Specificity.
    Chkheidze R; Burns DK; White CL; Castro D; Fuller J; Cai C
    J Neuropathol Exp Neurol; 2017 Apr; 76(4):323-331. PubMed ID: 28340105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophagic myofasciitis in children is a localized reaction to vaccination.
    Lach B; Cupler EJ
    J Child Neurol; 2008 Jun; 23(6):614-9. PubMed ID: 18281624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-linear dose-response of aluminium hydroxide adjuvant particles: Selective low dose neurotoxicity.
    Crépeaux G; Eidi H; David MO; Baba-Amer Y; Tzavara E; Giros B; Authier FJ; Exley C; Shaw CA; Cadusseau J; Gherardi RK
    Toxicology; 2017 Jan; 375():48-57. PubMed ID: 27908630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Post-vaccination granuloma due to aluminium hydroxide].
    Bordet AL; Michenet P; Cohen C; Arbion F; Ekindi N; Bonneau C; Kerdraon R; Coville M
    Ann Pathol; 2001 Apr; 21(2):149-52. PubMed ID: 11373585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical presentation of macrophagic myofasciitis 10 years post vaccination.
    Ryan AM; Bermingham N; Harrington HJ; Keohane C
    Neuromuscul Disord; 2006 Dec; 16(12):867-9. PubMed ID: 17005400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EBER in situ hybridization in subcutaneous aluminum granulomas/lymphoid hyperplasia: A diagnostic clue to differentiate injection-associated lymphoid hyperplasia from other forms of pseudolymphomas and cutaneous lymphomas.
    Frings VG; Roth S; Rosenwald A; Goebeler M; Geissinger E; Wobser M
    J Cutan Pathol; 2021 May; 48(5):625-631. PubMed ID: 33496022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vaccine adjuvants and macrophagic myofasciitis].
    Siegrist CA
    Bull Acad Natl Med; 2003; 187(8):1511-8; discussion 1519-21. PubMed ID: 15146582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of aluminium to neonatal mice in vaccine-relevant amounts is associated with adverse long term neurological outcomes.
    Shaw CA; Li Y; Tomljenovic L
    J Inorg Biochem; 2013 Nov; 128():237-44. PubMed ID: 23932735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent subcutaneous nodules in patients hyposensitized with aluminum-containing allergen extracts.
    García-Patos V; Pujol RM; Alomar A; Cisteró A; Curell R; Fernández-Figueras MT; de Moragas JM
    Arch Dermatol; 1995 Dec; 131(12):1421-4. PubMed ID: 7492132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous B-cell pseudolymphoma at the site of vaccination.
    Cerroni L; Borroni RG; Massone C; Chott A; Kerl H
    Am J Dermatopathol; 2007 Dec; 29(6):538-42. PubMed ID: 18032948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro study of percutaneous absorption of aluminum from antiperspirants through human skin in the Franz™ diffusion cell.
    Pineau A; Guillard O; Favreau F; Marrauld A; Fauconneau B
    J Inorg Biochem; 2012 May; 110():21-6. PubMed ID: 22459170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.